Detalles de la búsqueda
1.
Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [18F]FDG-PET/MRI.
Eur J Nucl Med Mol Imaging;
51(5): 1451-1461, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38133687
2.
High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancer.
Arch Gynecol Obstet;
309(6): 2789-2798, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38413424
3.
Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times.
Eur Radiol;
33(9): 6179-6188, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37045980
4.
Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer.
Eur J Nucl Med Mol Imaging;
49(3): 992-1001, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34476552
5.
Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients.
Eur Radiol;
31(11): 8714-8724, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33912991
6.
Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients.
Cell Mol Life Sci;
77(3): 497-509, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31254045
7.
Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple-negative breast cancer patients.
J Cell Mol Med;
24(15): 8405-8416, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32558176
8.
High serum levels of periostin are associated with a poor survival in breast cancer.
Breast Cancer Res Treat;
180(2): 515-524, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32040688
9.
Prospective evaluation of whole-body MRI and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients.
Eur J Nucl Med Mol Imaging;
47(12): 2816-2825, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32333068
10.
Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer.
BMC Cancer;
19(1): 120, 2019 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30717704
11.
Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI.
Eur J Nucl Med Mol Imaging;
45(13): 2328-2337, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30056547
12.
Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
Breast Cancer Res;
18(1): 20, 2016 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26868521
13.
Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse.
J Cancer Res Clin Oncol;
149(3): 1159-1174, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35366112
14.
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients.
Front Immunol;
14: 1188030, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37283737
15.
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer.
Cancers (Basel);
15(6)2023 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980537
16.
Conventional Imaging, MRI and 18F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer.
Cancers (Basel);
15(14)2023 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509307
17.
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine Learning.
J Nucl Med;
64(2): 304-311, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36137756
18.
The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant Chemotherapy.
Breast Care (Basel);
17(4): 371-376, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36156910
19.
A Role of PET/MR in Breast Cancer?
Semin Nucl Med;
52(5): 611-618, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260243
20.
Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI-Clinically Relevant?
Cancers (Basel);
14(14)2022 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35884513